VISIOPHARM A/S: Financial statements 2022
CVR: 26186676
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
VISIOPHARM A/S (CVR 26186676) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 135,974,000 and a net result of DKK -20,612,000 compared with DKK -41,341,000 the year before. That is an increase of 25.3% compared with the year before. The profit margin was -15.2%. Equity in the 2022 report amounted to DKK 33,904,000. The solvency ratio was 31.5%. The company had 105 employees in the financial year.
- Revenue
- DKK 135,974,000
- Gross Profit
- DKK 84,161,000
- Profit/Loss
- DKK -20,612,000
- Equity
- DKK 33,904,000
- Total Assets
- DKK 107,596,000
- Employees
- 105
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 136M | 84.2M | -20.6M | 33.9M | 105 |
| 2021 | 108.5M | 45.3M | -41.3M | 59.4M | - |
| 2020 | 84.3M | 44.5M | -26.3M | 100.5M | - |
| 2019 | 87.9M | 33.7M | 21.7M | 77.1M | - |
| 2018 | 56.2M | 22.2M | -12M | 99.3M | - |
Official annual report
Keep an eye on VISIOPHARM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout VISIOPHARM A/S
VISIOPHARM A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2001. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named VISIOPHARM ApS. The management consists of Johan Doré Hansen and Michael Grunkin. The board consists of Evis Hursever (chair), Andrew James Thomson and Per Fredrik Thorell. The company is owned by Neptune Denmark Holdco ApS. The company has 56 employees (2026). In 2025, the company reported revenue of DKK 130,617,000 and a net result of DKK -17,223,000 compared with DKK -17,363,000 the year before. Equity in the 2025 report amounted to DKK -4,949,000.